Dr. Weixuan Wang is a scientist whose research focuses on Antibody Engineering, Cancer Immunotherapy, and Immunoassay.

He obtained his B.S. and Ph.D. degrees in Biology from China Agricultural University, followed by a postdoctoral research appointment at the Tsinghua University Shenzhen International Graduate School - Shenzhen Bay Laboratory. Dr. Wang’s long-standing research commitment spans the domains of Antibody Engineering and Synthetic Biology. His scholarly output is evidenced by 14 SCI publications as a first or co-author and 2 first-author papers in Chinese core journals. Furthermore, he holds 2 patents as the primary student inventor. Beyond academia, Dr. Wang possesses substantial experience in research commercialization, having held R&D Director positions in multiple industrial settings, including those focused on Synthetic Biology, Dermocosmetics, and In Vitro Diagnostics (IVD).